Lebensgefahr: orale Glykoprotein-IIb/IIIa-Antagonisten

  • m -- Chew DP, Bhatt DL, Sapp S et al. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: A meta-analysis of phase III multicenter randomized trials. Circulation 2001 (16. Januar); 103: 201-6 [Link]